Patents by Inventor Sheldon Saul Hendler

Sheldon Saul Hendler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8709434
    Abstract: Phycobilins are disclosed to have prodrug activity as inhibitors of NADPH oxidase activity and are disclosed to be useful in the prophylaxis and/or treatment of medical conditions associated with or linked to an NADPH oxidase activity. Compositions containing phycobilins are described which facilitate the administration of phycobilins.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: April 29, 2014
    Assignee: PCB Associates, Inc.
    Inventors: Mark Fredrick McCarty, Sheldon Saul Hendler, David Michael Rorvik, Toyoshi Inoguchi
  • Publication number: 20100172971
    Abstract: Phycobilins are disclosed to have prodrug activity as inhibitors of NADPH oxidase activity and are disclosed to be useful in the prophylaxis and/or treatment of medical conditions associated with or linked to an NADPH oxidase activity. Compositions containing phycobilins are described which facilitate the administration of phycobilins.
    Type: Application
    Filed: November 13, 2007
    Publication date: July 8, 2010
    Inventors: Mark Fredrick McCarty, Sheldon Saul Hendler, David Michael Rorvik, Toyoshi Inoguchi
  • Patent number: 5874478
    Abstract: This invention relates to compounds, compositions, uses and methods for inhibiting viral and retroviral replication and for treating viral and retroviral infections via the administration of various compounds, including antioxidants, preferably compounds corresponding to the formula ##STR1## wherein n=1, 2, 3, or 4; m=0 or 1; X is O, S or CH.sub.2 ; R.sub.1 is hydrogen or tertiary butyl or lower alkyl of from one to six carbon atoms, inclusive; R.sub.2 is tertiary butyl or lower alkyl of from one to six carbon atoms, inclusive; and R.sub.3 is hydrogen or alkyl or aryl or mixed alkyl/aryl, containing a total of 5-25 carbon atoms.
    Type: Grant
    Filed: September 30, 1993
    Date of Patent: February 23, 1999
    Assignee: Vyrex Corporation
    Inventors: Sheldon Saul Hendler, Robert A. Sanchez, Tara